MIDDLE EAST AND AFRICA STEM CELL MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

MIDDLE EAST AND AFRICA STEM CELL MARKET 2021-2028

Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

In its research report, Triton has established that the stem cell market in the Middle East and Africa is predicted to witness growth at a compound annual growth rate of 6.50% in the calculated years of 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered for analysis in this market are:

•        The United Arab Emirates

•        Israel

•        Turkey

•        South Africa

•        Saudi Arabia

•        Rest of Middle East & Africa

Over the years, there has been significant growth in cancer occurrence in the United Arab Emirates. Earlier, the Emirates Hospital Jumeirah connected with ReGen Medical Management Dubai to initiate a novel stem cell and regenerative medical center. Moreover, the hospital is the first to provide a range of specialty regenerative services across the United Arab Emirates. Hence, such developments, coupled with a high prevalence of various types of cancer, enhance the need for stem cell therapies, in turn, fueling the progress of the stem cell market in the Emirates.

Turkey’s stem cell research and cancer treatment facilities have developed significantly over the years. Moreover, several medical tourists visit the country seeking high-quality and low-cost stem cell treatment. Additionally, the Turkey Stem Cell Transplantation Nursing was established as a sub-committee of the Oncology Nursing Association of the Republic of Turkey, which indicates the high growth of stem cell therapies and research. Therefore, the rising stem cell transplants, along with a surge in research activities, are likely to advance the progress of the stem cell market across Turkey.

Corning Inc manufactures and markets ceramic, specialty glasses, and related materials. Its business segments include optical communication, life science, display technology, environmental technologies, and specialty material. The company’s life science segment comprise consumables such as specialty surface, along with equipment for cell culture research, drug discovery, microbiology, and bioprocessing, among others. It offers its products in various regions, including the Middle East and Africa. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA STEM CELL MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1. THREAT OF NEW ENTRANTS

2.1.2. THREAT OF SUBSTITUTE PRODUCTS

2.1.3. BARGAINING POWER OF BUYERS

2.1.4. BARGAINING POWER OF SUPPLIERS

2.1.5. COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON STEM CELL MARKET

2.3. KEY IMPACT ANALYSIS

2.4. INDUSTRY COMPONENTS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. KEY INSIGHTS

2.8. MARKET DRIVERS

2.8.1. GROWING AWARENESS ABOUT UMBILICAL CORD STEM CELLS

2.8.2. SURGE IN STEM CELL RESEARCH AND DEVELOPMENT

2.8.3. RISING DEMAND FOR REGENERATIVE MEDICINE

2.9. MARKET RESTRAINTS

2.9.1.   ETHICAL CONCERNS ASSOCIATED WITH STEM CELLS

2.9.2.   HIGH COST OF STEM CELL PROCEDURES

2.9.3.   STRINGENT REGULATIONS IN TERMS OF STEM CELL THERAPY

2.10. MARKET OPPORTUNITIES

2.10.1. ADVANCEMENT IN TECHNOLOGY

2.10.2. RISK OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS

3.    MIDDLE EAST AND AFRICA STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. NEUROLOGICAL DISORDERS

3.2. ONCOLOGY DISORDERS

3.3. DIABETES

3.4. INJURIES AND WOUNDS

3.5. ORTHOPEDIC TREATMENTS

3.6. CARDIOVASCULAR DISORDERS

3.7. OTHER THERAPEUTIC APPLICATIONS

4.    MIDDLE EAST AND AFRICA STEM CELL MARKET OUTLOOK - BY TECHNOLOGY

4.1. CRYOPRESERVATION

4.2. ACQUISITION

4.2.1. STEM CELL APHERESIS

4.2.2. STEM CELL BONE MARROW MARKET

4.2.3. STEM CELL UMBILICAL CORD

4.3. EXPANSION AND SUB-CULTURE

4.4. PRODUCTION

4.4.1. STEM CELL CULTURE

4.4.2. THERAPEUTIC CLONING

4.4.3. IVF

5.    MIDDLE EAST AND AFRICA STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE

5.1. ALLOGENEIC STEM CELL THERAPY

5.2. AUTOLOGIC STEM CELL THERAPY

5.3. SYNGENEIC STEM CELL THERAPY

6.    MIDDLE EAST AND AFRICA STEM CELL MARKET OUTLOOK - BY PRODUCT

6.1. ADULT STEM CELL

6.1.1. HEMATOPOIETIC STEM CELL

6.1.2. NEURAL STEM CELL

6.1.3. UMBILICAL CORD STEM CELL

6.1.4. MESENCHYMAL STEM CELL

6.1.5. DENTAL STEM CELL

6.2. HUMAN EMBRYONIC STEM CELL

6.3. PLURIPOTENT

6.4. MOUSE/RAT NEURAL

7.    MIDDLE EAST AND AFRICA STEM CELL MARKET OUTLOOK – BY APPLICATION

7.1. REGENERATIVE MEDICINE

7.2. DRUG DISCOVERY AND DEVELOPMENT

8.    GEOGRAPHICAL ANALYSIS - MIDDLE EAST AND AFRICA

8.1. COUNTRY ANALYSIS

8.1.1. ISRAEL

8.1.2. SAUDI ARABIA

8.1.3. UNITED ARAB EMIRATES

8.1.4. TURKEY

8.1.5. SOUTH AFRICA

8.1.5. REST OF MIDDLE EAST & AFRICA

9.    COMPANY PROFILES

9.1. CORNING INC

9.2. STEMCELL TECHNOLOGIES

9.3. STRYKER CORPORATION

9.4. BECTON DICKINSON AND COMPANY (BD)

9.5. CYTORI THERAPEUTICS

9.6. QIAGEN NV

9.7. GE HEALTHCARE

9.8. TAKARA HOLDINGS

9.9. SMITH & NEPHEW PLC

9.10. INTERNATIONAL STEM CELL CORP

9.11. MILTENYI BIOTEC

9.12. MERCK KGAA (SIGMA ALDRICH)

9.13. THERMO FISHER SCIENTIFIC INC

9.14. ALLCELLS LLC

9.15. PLURISTEM THERAPEUTICS INC

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.1.1. OBJECTIVES OF STUDY

10.1.2. SCOPE OF STUDY

10.2. SOURCES OF DATA

10.2.1. PRIMARY DATA SOURCES

10.2.2. SECONDARY DATA SOURCES

10.3. RESEARCH METHODOLOGY

10.3.1. EVALUATION OF PROPOSED MARKET

10.3.2. IDENTIFICATION OF DATA SOURCES

10.3.3. ASSESSMENT OF MARKET DETERMINANTS

10.3.4. DATA COLLECTION

10.3.5. DATA VALIDATION & ANALYSIS

List of table

TABLE 1        MIDDLE EAST AND AFRICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        MIDDLE EAST AND AFRICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4        MIDDLE EAST AND AFRICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 5        MIDDLE EAST AND AFRICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6        MIDDLE EAST AND AFRICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 7        MIDDLE EAST AND AFRICA STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 8        MIDDLE EAST AND AFRICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 9        MIDDLE EAST AND AFRICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 11      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1      MIDDLE EAST AND AFRICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 2      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 3      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 4      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

FIGURE 5      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

FIGURE 6      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 8      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9      MIDDLE EAST AND AFRICA STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

FIGURE 10   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

FIGURE 11   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 12   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

FIGURE 13   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

FIGURE 14   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 15   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

FIGURE 16   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 17   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

FIGURE 18   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

FIGURE 19   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 20   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 21   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 22   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 23   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 24   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY NEURAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 25   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 26   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 27   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 28   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 29   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

FIGURE 30   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

FIGURE 31   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32   MIDDLE EAST AND AFRICA STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 33   ISRAEL STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 34   SAUDI ARABIA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 35   UNITED ARAB EMIRATES STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 36   TURKEY STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 37   SOUTH AFRICA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 38   REST OF MIDDLE EAST & AFRICA STEM CELL MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;